| Insider | Sandercock Brett |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | ResMed Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 2, 2026 |
| Shares Sold | 1,000 |
| Price per Share | $257.03 |
| Total Value | $257,030.00 |
| Shares Owned After | 85,495 |
| Derivative | No |
| Accession Number | 0000943819-26-000008 |
| Document | View SEC Filing |